U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618026) titled 'Establishing Effects of Bacillus Clausii Probiotic Consumption on Gastrointestinal Health and Inflammation' on Feb. 16.
Brief Summary: The study is a randomized, double-blind, crossover, placebo-controlled clinical intervention trial to test the effects of a commercial Bacillus (Shouchella) clausii probiotic compared to a placebo on gastrointestinal symptoms.
Study Start Date: March 28, 2024
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal Health
Intervention:
DIETARY_SUPPLEMENT: Bacillus (Shouchella) clausii CSI08
Gram-positive, spore-forming microorganism
OTHER: Placebo
Inert filler material delivered in a capsule id...